Robot-Assisted surgery for lung cancer and thymus disease put to the test
NCT ID NCT05150210
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new robotic surgery system, the da Vinci SP, for removing part or all of a lung (lobectomy) or the thymus gland (thymectomy) in people with lung cancer, benign lung disease, thymoma, or myasthenia gravis. The goal is to see if the robot can perform these surgeries safely without needing to switch to a different method. Thirty-two adults will be enrolled and followed for 30 days after surgery, with long-term follow-up for up to 5 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
da Vinci SP Surgical System (robotic-assisted surgery device)
What this could lead to
If successful, this could show that the da Vinci SP robot is a safe and effective tool for minimally invasive lung and thymus surgeries.
What could go wrong
This is a small, early-stage study with only 32 participants, so results may not apply to everyone. There are always risks with surgery, such as complications or the need to switch to a different approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYASTHENIA GRAVIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Duke University Hospital
Durham, North Carolina, 27710, United States
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
NYU Langone Health
New York, New York, 10016, United States